NYSEAMERICAN : RVP
Retractable Technologies, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 0.565 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 16.91M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 16.95M |
| Enterprise Value | -21.95M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 29.94M |
| Shares Outstanding | 29.94M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 59.23% |
| Owned by Institutions (%) | 8.81% |
| Float | 12.21M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.50 |
| Forward PS | n/a |
| PB Ratio | 0.23 |
| P/TBV Ratio | 0.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.93 |
| Quick Ratio | 3.68 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -267.12 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -4.52% |
| Return on Assets (ROA) | -9.40% |
| Return on Invested Capital (ROIC) | -62.40% |
| Return on Capital Employed (ROCE) | -16.93% |
| Weighted Average Cost of Capital (WACC) | 11.20% |
| Revenue Per Employee | $168,673 |
| Profits Per Employee | -$17,920 |
| Employee Count | 201 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 1.89 |
Taxes
| Measure | Value |
|---|
| Income Tax | 7,392 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.31 |
| 52-Week Price Change | -35.62% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 0.68 |
| Relative Strength Index (RSI) | 22.58 |
| Average Volume (20 Days) | 37,663 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 27,206 |
| Short Previous Month | 62,183 |
| Short % of Shares Out | 0.09% |
| Short % of Float | 0.22% |
| Short Ratio (days to cover) | 0.76 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 33.90M |
| Gross Profit | -491,509 |
| Operating Income | -21.73M |
| Pretax Income | -3.36M |
| Net Income | -3.60M |
| EBITDA | -13.92M |
| EBIT | -21.73M |
| Loss Per Share | -$0.12 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 39.87M |
| Total Debt | 973,895 |
| Net Cash | 38.90M |
| Net Cash Per Share | $1.30 |
| Equity (Book Value) | 72.87M |
| Book Value Per Share | 2.43 |
| Working Capital | 52.56M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -4.96M |
| Capital Expenditures | -152,410 |
| Depreciation & Amortization | 7.81M |
| Net Borrowing | -401,594 |
| Free Cash Flow | -5.11M |
| FCF Per Share | -$0.17 |
Margins
| Measure | Value |
|---|
| Gross Margin | -1.45% |
| Operating Margin | -64.09% |
| Pretax Margin | -9.92% |
| Profit Margin | -9.94% |
| EBITDA Margin | -41.04% |
| EBIT Margin | -64.09% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -21.25% |
| FCF Yield | -30.20% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.5 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |